Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5857757 | Regulatory Toxicology and Pharmacology | 2012 | 15 Pages |
Abstract
⺠Nonlinear-threshold carcinogenic assessments should be considered for CrVI. ⺠A health-protective, cancer-based chronic ReV of 0.24 μg CrVI/m3 was derived. ⺠Chronic ReV is 300 times the EPA URF-based 1E-05 excess risk air concentration. ⺠The ReV will ultimately be compared to the 1E-05 air level based on TCEQ's URF.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Joseph T. Jr., Neeraja Erraguntla, Robert L. Jr., Ciriaco Valdez-Flores,